We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAF icon
1276
First American
FAF
$7.66B
$129K 0.01%
2,498
-9,995
-80% -$533K
FDS icon
1277
Factset
FDS
$9.89B
$129K 0.01%
650
-3,772
-85% -$753K
IDCC icon
1278
InterDigital
IDCC
$8.53B
$129K 0.01%
1,601
+445
+38% +$35.4K
ALG icon
1279
Alamo Group
ALG
$2.04B
$128K 0.01%
1,421
-2,659
-65% -$270K
CFR icon
1280
Cullen/Frost Bankers
CFR
$10.3B
$128K 0.01%
1,189
-2,566
-68% -$290K
COHR icon
1281
Coherent
COHR
$64.2B
$128K 0.01%
+2,956
New +$130K
CWEN icon
1282
Clearway Energy Class C
CWEN
$4.86B
$128K 0.01%
7,395
+4,167
+129% +$73K
FXD icon
1283
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
$128K 0.01%
3,008
-16,548
-85% -$688K
GRMN
1284
Garmin
GRMN
$58.3B
$128K 0.01%
2,103
+2,041
+3,292% +$123K
TGNA
1285
DELISTED
TEGNA Inc
TGNA
$128K 0.01%
11,788
-5,442
-32% -$59K
BCOV
1286
DELISTED
Brightcove, Inc.
BCOV
$128K 0.01%
13,313
-6,825
-34% -$62.9K
ALDR
1287
DELISTED
Alder Biopharmaceuticals
ALDR
$128K 0.01%
+8,054
New +$122K
ULTI
1288
DELISTED
Ultimate Software Group Inc
ULTI
$128K 0.01%
495
-1,719
-78% -$441K
ARRS
1289
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$128K 0.01%
5,245
-11,374
-68% -$299K
NGVT icon
1290
Ingevity
NGVT
$2.65B
$127K 0.01%
1,567
-4,593
-75% -$365K
TER icon
1291
Teradyne
TER
$60.9B
$127K 0.01%
3,335
-30,515
-90% -$1.19M
FLG
1292
Flagstar Bank National Association
FLG
$5.96B
$127K 0.01%
3,834
-1,063
-22% -$38.2K
TSG
1293
DELISTED
The Stars Group Inc.
TSG
$127K 0.01%
+3,500
New +$117K
DDS icon
1294
Dillards
DDS
$9.63B
$126K 0.01%
1,335
+545
+69% +$44.4K
DVY icon
1295
iShares Select Dividend ETF
DVY
$23.5B
$126K 0.01%
1,294
-36,046
-97% -$3.5M
BRSL
1296
Brightstar Lottery PLC
BRSL
$2.08B
$126K 0.01%
5,440
+340
+7% +$9.05K
NRIM icon
1297
Northrim BanCorp
NRIM
$600M
$126K 0.01%
12,696
+9,244
+268% +$87.1K
WABC icon
1298
Westamerica Bancorp
WABC
$1.38B
$126K 0.01%
2,238
+1,703
+318% +$98.4K
GGG icon
1299
Graco
GGG
$13.4B
$125K 0.01%
2,763
-12,009
-81% -$551K
STLD icon
1300
Steel Dynamics
STLD
$38.1B
$125K 0.01%
2,729
-13,637
-83% -$645K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.